Funder
National Natural Science Foundation of China
Natural Science Foundation of Shandong Province
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Ferenc T, Sygut J, Kopczynski J, Mayer M, Latos-Bielenska A, Dziki A, Kulig A (2006) Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background. Pol J Pathol 57:5–15
2. van Houdt WJ, Husson O, Patel A, Jones RL, Smith MJF, Miah AB, Messiou C, Moskovic E, Al-Muderis O, Benson C, Zaidi S, Dunlop A, Strauss DC, Hayes AJ, van der Graaf WTA (2019) Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance. Ann Surg Oncol 26:4699–4706. https://doi.org/10.1245/s10434-019-07826-6
3. Desmoid Tumor Working G (2020) The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer 127:96–107. https://doi.org/10.1016/j.ejca.2019.11.013
4. Federman N (2022) Molecular pathogenesis of desmoid tumor and the role of gamma-secretase inhibition. NPJ Precis Oncol 6:62. https://doi.org/10.1038/s41698-022-00308-1
5. Penel N, Chibon F, Salas S (2017) Adult desmoid tumors: biology, management and ongoing trials. Curr Opin Oncol 29:268–274. https://doi.org/10.1097/CCO.0000000000000374